Physician profile
Anna Sorokin
NPI 1881861342
$7,445.49
in general payments reported to CMS, 2019-2025
39 companies · $2,178 in 2025
The $2,178 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.83 · 2020: $298 · 2021: $1,926 · 2022: $444 · 2023: $827 · 2024: $1,749 · 2025: $2,178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,655 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,654.82 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,091.83 | 2021-2025 | Ubrelvy, Qulipta, Duopa |
| Abbott Laboratories | $1,249.13 | 2021-2024 | Eterna, Infinity |
| Pfizer INC. | $462.81 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $439.61 | 2020-2025 | Austedo Xr, Austedo Xr |
| Neurocrine Biosciences, INC. | $286.61 | 2023-2025 | Ingrezza, Ongentys |
| Lilly USA, LLC | $273.65 | 2024-2025 | Kisunla, Emgality, Amyvid |
| Boston Scientific Corporation | $214.41 | 2021 | |
| Medtronic, INC. | $204.40 | 2024 | Percept PC Brainsense |
| Biohaven Pharmaceuticals, INC. | $202.19 | 2021 | |
| Acadia Pharmaceuticals INC | $179.39 | 2022-2025 | Nuplazid |
| Novartis Pharmaceuticals Corporation | $166.91 | 2019-2025 | |
| Insightec,INC | $166.18 | 2020 | |
| Inspire Medical Systems, INC. | $160.62 | 2024 | Inspire |
| Biogen, INC. | $153.05 | 2024-2025 | Vumerity, Tysabri, Skyclarys |
| Acorda Therapeutics, INC | $123.31 | 2023 | Inbrija |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $96.16 | 2021-2025 | Rytary, Crexont |
| Mdd US Operations, LLC | $84.17 | 2024-2025 | Gocovri |
| Genentech USA, INC. | $72.70 | 2024 | Ocrevus, Ocrevus Zunovo |
| Axsome Therapeutics, INC. | $65.82 | 2025 | Symbravo, Sunosi |
| Eisai INC. | $62.90 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $62.10 | 2025 | Wainua |
| Biohaven Pharmaceutical Holding Company LTD. | $60.38 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $57.68 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $51.55 | 2025 | Dysport |
| Amgen INC. | $51.27 | 2023-2024 | Aimovig |
| Xeris Pharmaceuticals, INC. | $41.17 | 2024-2025 | Keveyis |
| Ucb, INC. | $39.75 | 2025 | Rystiggo |
| Jazz Pharmaceuticals INC. | $39.42 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.90 | 2023-2025 | Hyqvia |
| Lundbeck LLC | $35.51 | 2025 | Vyepti |
| Argenx US, INC. | $31.45 | 2025 | Vyvgart Hytrulo |
| Sk Life Science, INC. | $30.14 | 2023 | |
| Supernus Pharmaceuticals, INC. | $29.20 | 2025 | Qelbree |
| Tg Therapeutics, INC. | $24.95 | 2024 | |
| Tanabe Pharma America, INC. | $24.51 | 2025 | Radicava |
| Janssen Biotech, INC. | $24.18 | 2025 | |
| Azurity Pharmaceuticals, INC. | $24.05 | 2025 | Horizant |
| Medtronic USA, INC. | $13.42 | 2020 | |
| Corium, LLC | $12.01 | 2023 | Adlarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Sorokin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.